https://www.wsj.com/articles/amgen-in-advanced-talks-to-buy-horizon-therapeutics-11670785882
0
0
26 words
0
Comments
U.S. biotechnology company will pay $116.50 for each Horizon share
You are the first to view
Create an account or login to join the discussion